Australia markets closed

Viridian Therapeutics, Inc. (VRDN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
17.40-0.11 (-0.63%)
As of 10:22AM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
314
314
1,772
2,963
1,050
Operating expenses
Research development
159,765
159,765
100,894
56,886
28,304
Selling general and administrative
94,999
94,999
35,182
25,805
13,265
Total operating expenses
254,764
254,764
136,076
82,691
41,569
Operating income or loss
-254,450
-254,450
-134,304
-79,728
-40,519
Interest expense
1,847
1,847
486
3
508
Total other income/expenses net
-
-
-
-
-69,861
Income before tax
-237,734
-237,734
-129,874
-79,413
-110,715
Income from continuing operations
-237,734
-237,734
-129,874
-79,413
-110,715
Net income
-237,734
-237,734
-129,874
-79,413
-110,715
Net income available to common shareholders
-237,734
-237,734
-129,874
-79,413
-110,715
Basic EPS
-5.14
-5.31
-4.05
-6.66
-31.13
Diluted EPS
-5.14
-5.31
-4.05
-6.66
-31.13
Basic average shares
42,452
44,755
32,087
11,919
3,557
Diluted average shares
42,452
44,755
32,087
11,919
3,557